Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Catalyst Pharmaceuticals Inc CPRX

Healthcare Biotechnology
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on developing and commercializing first-in-class medicines that address rare and difficult to treat diseases. Its flagship commercial product is FIRDAPSE (amifampridine) tablets 10 milligrams (mg), approved for the treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) for adults and for... see more

Recent & Breaking News (NDAQ:CPRX)

Catalyst Pharmaceuticals to Hold Third Quarter Financial Results Conference Call and Webcast on Thursday, November 10th, 2016

GlobeNewswire November 1, 2016

Research Reports Coverage on Generic Drugs Stocks -- Evoke Pharma, Catalyst Pharma, Neurocrine Biosciences, and Galectin Therapeutics

PR Newswire October 31, 2016

Catalyst Pharmaceuticals Receives Special Protocol Assessment (SPA) from the FDA for Second Phase 3 Clinical Trial Evaluating Firdapse for the Treatment of LEMS

GlobeNewswire October 31, 2016

Catalyst Pharmaceuticals to Present at 15th Annual BIO Investor Forum

GlobeNewswire October 13, 2016

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  October 5, 2016

Mid-Day Market Update: Crude Oil Up Over 2%; AZZ Shares Drop Following Q2 Results

Benzinga.com  October 5, 2016

Mid-Morning Market Update: Markets Open Higher; Constellation Brands Tops Q2 Views

Benzinga.com  October 5, 2016

Catalyst Pharmaceuticals Announces Publication of CPP-115 Clinical Efficacy Data for Infantile Spasms in Epilepsy & Behavior Case Reports

GlobeNewswire September 19, 2016

Catalyst Pharmaceuticals Announces Launch of Expanded Access Program Website and Participation at the American Association of Neuromuscular & Electrodiagnostic Medicine Conference

GlobeNewswire September 14, 2016

Catalyst Pharmaceuticals to Present at Rodman & Renshaw’s 18th Annual Global Investment Conference

GlobeNewswire September 8, 2016

Catalyst Pharmaceuticals Announces FDA Orphan Drug Designation of Firdapse for the Treatment of Myasthenia Gravis

GlobeNewswire September 2, 2016

Catalyst Pharmaceuticals Announces Second Quarter 2016 Financial Results and Provides Product Development Update

GlobeNewswire August 9, 2016

Catalyst Pharmaceuticals to Hold Second Quarter Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 10th, 2016

GlobeNewswire August 1, 2016

8 Biggest Mid-Day Gainers For Monday

Benzinga.com  June 13, 2016

10 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  June 13, 2016

Catalyst Pharmaceuticals Announces Agreement with FDA on Confirmatory Phase 3 Study Protocol for Firdapse in Lambert-Eaton Myasthenic Syndrome

GlobeNewswire June 13, 2016

Technical Analysis on Drugs - Generic Equities -- Akorn, Ironwood Pharma, Catalyst Pharma, and Pacira Pharma

PR Newswire June 10, 2016

Catalyst Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference

GlobeNewswire June 1, 2016

Catalyst Pharmaceutical’s Firdapse Phase 3 Study Published in Muscle & Nerve

GlobeNewswire May 18, 2016

Catalyst Pharmaceuticals Announces Reduction in Workforce as Part of Operating Expense Management Plan

GlobeNewswire May 17, 2016